Early serum infliximab trough level and mucosal healing could be predictors for one-year outcome after initiating therapy in Crohn's disease.
Jian TangQingfan YangZicheng HuangHuili GuoKang ChaoPinjin HuXiang GaoPublished in: Scandinavian journal of gastroenterology (2020)
Early S-IFX and early MH could predict one-year response after initiating IFX therapy in Crohn's disease.
Keyphrases